UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 6, 2021
Accession Number:
0001104659-21-123124
Submission Type:
POS AM
CIK:
0001634432
Company Name:
Strongbridge Biopharma plc
File Number:
333-223575